Asian patients with HBeAg-negative chronic hepatitis B respond well to peginterferon alfa-2a (40 KD) (PEGASYS®) treatment

被引：0
|
作者：
Jia, Ji-Dong
Piratvisuth, Teerha
Lau, George K. K.
Luo, Kang-Xian
Jin, Rui
Lu, Zhi-Meng
Marcellin, Patrick
Popescu, Matei
Button, Peter
机构：
[1] Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China
[2] Prince Songkla Univ, Songklanagarind Hosp, Hat Yai, Thailand
[3] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China
[4] Beijing You An Hosp, Beijing, Peoples R China
[5] Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China
[6] Univ Paris, Hop Beaujon, Serv Hepatol, Clichy, France
[7] Roche, Basel, Switzerland
[8] Roche, Dee Why, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A88 / A88
页数：1
相关论文
共 50 条
  • [1] Response to peginterferon alfa-2a (40KD) (PEGASYS) treatment in patients with bridging fibrosis in HBeAg-positive and HBeAg-negative chronic hepatitis B
    Cooksley, Graham
    Lau, George
    Marcellin, Patrick
    Piratvisuth, Teerha
    Lai, Ming-Yang
    Bonino, Ferruccio
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A32 - A32
  • [2] Extended Peginterferon Alfa-2a (Pegasys) Therapy in Chinese Patients With HBeAg-Negative Chronic Hepatitis B
    Chen, Xuefu
    Chen, Xiaoping
    Chen, Wenli
    Ma, Xiaojun
    Huang, Jing
    Chen, Ren
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (10) : 1705 - 1713
  • [3] Predicting response to peginterferon alfa-2a (40 KD) (PEGASYS®) in Asian patients with HBeAg-positive chronic hepatitis B
    Cooksley, Graham
    Chow, Wan Cheng
    Piratvisuth, Teerha
    Lau, George K. K.
    Mccloud, Philip
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A108 - A108
  • [4] The cost effectiveness analysis of treatment with peginterferon alfa-2a (40KD) in patients with hbeag-negative chronic hepatitis B
    Kowalik, E.
    Niewada, M.
    Jakubczyk, M.
    Horban, A.
    Berak, H.
    Szkultecka-Debek, M.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A300 - A300
  • [5] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Piratvisuth, Teerha
    Lau, George
    Chao, You-Chen
    Jin, Rui
    Chutaputti, Anuchit
    Zhang, Q. -B.
    Tanwandee, Tawesak
    Button, Peter
    Popescu, Matei
    [J]. HEPATOLOGY INTERNATIONAL, 2008, 2 (01) : 102 - 110
  • [6] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Teerha Piratvisuth
    George Lau
    You-Chen Chao
    Rui Jin
    Anuchit Chutaputti
    Q.-B. Zhang
    Tawesak Tanwandee
    Peter Button
    Matei Popescu
    [J]. Hepatology International, 2008, 2 : 102 - 110
  • [7] ALT flares and sustained ALT response in patients with HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS®), peginterferon alfa-2a (40KD) plus lamivudine or lamivudine alone
    Piratvisuth, T
    Marcellin, P
    Lau, G
    Bonino, F
    Farci, P
    Hadziyannis, S
    Jin, R
    Lu, ZM
    Germanidis, G
    Yurdaydin, C
    Diago, M
    Gurel, S
    Lai, MY
    Button, P
    Why, RD
    Pluck, N
    [J]. HEPATOLOGY, 2004, 40 (04) : 656A - 657A
  • [8] HBSAG LEVELS DURING THE FIRST 24 WEEKS OF PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: THE PERSEAS COHORT
    Goulis, I.
    Akriviadis, E.
    Karatapanis, S.
    Deutsch, M.
    Dalekos, G.
    Raptopoulou-Gigi, M.
    Drakoulis, C.
    Bakalos, G.
    Papatheodoridis, G.
    [J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S286 - S287
  • [9] Factors associated with sustained virologic response 1 year after treatment with peginterferon alfa-2A (40KD) (PEGASYS®) monotherapy for HBEAG-negative chronic hepatitis B
    Marcellin, P
    Bonino, F
    Lau, GY
    Farci, P
    Yurdaydin, C
    Piratvisuth, T
    Jin, R
    Gurel, S
    Hadziyannis, S
    Lu, ZM
    Popescu, M
    [J]. HEPATOLOGY, 2005, 42 (04) : 580A - 580A
  • [10] Durability of response to peginterferon alfa-2a (40 KD) (PEGASYS®) treatment in Asian patients with HBeAg-negative chronic hepatitis B:: 12 month follow-up data from a large randomised study
    Lau, George
    Marcellin, Patrick
    Piratvisuth, Teerha
    Jin, Rui
    Lu, Zhi-Meng
    Lai, Ming-Yang
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A33 - A33
12345